{"id":910765,"date":"2025-11-17T09:50:17","date_gmt":"2025-11-17T14:50:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/"},"modified":"2025-11-17T09:50:17","modified_gmt":"2025-11-17T14:50:17","slug":"caris-life-sciences-to-attend-q4-2025-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/","title":{"rendered":"Caris Life Sciences to Attend Q4 2025 Investor Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">IRVING, Texas<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Nov. 17, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4559531-1&amp;h=3275243525&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences\" target=\"_blank\" rel=\"nofollow\">Caris Life Sciences<\/a>\u00ae\u00a0(NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today\u00a0announced that the company will attend the following investor conferences:<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.jpg\" title=\"Caris Life Sciences Logo (PRNewsfoto\/Caris Life Sciences)\" alt=\"Caris Life Sciences Logo (PRNewsfoto\/Caris Life Sciences)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<ul type=\"disc\">\n<li>Wolfe Research&#8217;s 7th Annual Healthcare Conference: <span class=\"xn-location\">New York City<\/span>, <span class=\"xn-location\">New York<\/span>\n<ul type=\"disc\">\n<li>Investor meetings: <span class=\"xn-chron\">November 18<\/span><\/li>\n<\/ul>\n<\/li>\n<li>Citi&#8217;s 2025 Global Healthcare Conference: <span class=\"xn-location\">Miami, Florida<\/span>\n<ul type=\"disc\">\n<li>Investor meetings: <span class=\"xn-chron\">December 3<\/span><\/li>\n<\/ul>\n<\/li>\n<li>8<sup>th<\/sup>\u00a0Annual Evercore Healthcare Conference: <span class=\"xn-location\">Miami, Florida<\/span>\n<ul type=\"disc\">\n<li>Investor meetings: <span class=\"xn-chron\">December 4<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Contact <a href=\"mailto:InvestorRelations@CarisLS.com\" target=\"_blank\" rel=\"nofollow\">IR@CarisLS.com<\/a>\u00a0to schedule meetings.<\/p>\n<p>\n        <b><br \/>\n          <u>About Caris Life Sciences<br \/><\/u><br \/>\n        <\/b>Caris Life Sciences\u00ae (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms at scale, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies, and high-performance computing provides a differentiated platform to develop the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development.\u00a0<\/p>\n<p>Caris was founded with a vision to realize the potential of precision medicine in order to improve the human condition.\u00a0 Headquartered in <span class=\"xn-location\">Irving, Texas<\/span>, Caris has offices in <span class=\"xn-location\">Phoenix, New York<\/span>, <span class=\"xn-location\">Cambridge<\/span> (MA), <span class=\"xn-location\">Tokyo, Japan<\/span> and <span class=\"xn-location\">Basel, Switzerland<\/span>. Caris or its distributor partners provide services in the U.S. and other international markets.\u00a0<\/p>\n<p>\n        <b>Caris Life Sciences Media: <\/b>\u00a0<br \/>Corporate Communications <br \/><a href=\"mailto:CorpComm@CarisLS.com\" target=\"_blank\" rel=\"nofollow\">CorpComm@CarisLS.com<\/a><br \/>214.294.5606\u00a0<\/p>\n<p>\n        <b>Investor Relations:<\/b><br \/>\n        <br \/>\n        <a href=\"mailto:IR@CarisLS.com\" target=\"_blank\" rel=\"nofollow\">IR@CarisLS.com<\/a><br \/>\n        <br \/>917.689.3511<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=DA25699&amp;sd=2025-11-17\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/caris-life-sciences-to-attend-q4-2025-investor-conferences-302616558.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/caris-life-sciences-to-attend-q4-2025-investor-conferences-302616558.html<\/a><\/p>\n<p>SOURCE  Caris Life Sciences<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DA25699&amp;Transmission_Id=202511170830PR_NEWS_USPR_____DA25699&amp;DateId=20251117\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire IRVING, Texas , Nov. 17, 2025 \/PRNewswire\/ &#8212;\u00a0Caris Life Sciences\u00ae\u00a0(NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today\u00a0announced that the company will attend the following investor conferences: Wolfe Research&#8217;s 7th Annual Healthcare Conference: New York City, New York Investor meetings: November 18 Citi&#8217;s 2025 Global Healthcare Conference: Miami, Florida Investor meetings: December 3 8th\u00a0Annual Evercore Healthcare Conference: Miami, Florida Investor meetings: December 4 Contact IR@CarisLS.com\u00a0to schedule meetings. About Caris Life Sciences Caris Life Sciences\u00ae (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Caris Life Sciences to Attend Q4 2025 Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-910765","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Caris Life Sciences to Attend Q4 2025 Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caris Life Sciences to Attend Q4 2025 Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire IRVING, Texas , Nov. 17, 2025 \/PRNewswire\/ &#8212;\u00a0Caris Life Sciences\u00ae\u00a0(NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today\u00a0announced that the company will attend the following investor conferences: Wolfe Research&#8217;s 7th Annual Healthcare Conference: New York City, New York Investor meetings: November 18 Citi&#8217;s 2025 Global Healthcare Conference: Miami, Florida Investor meetings: December 3 8th\u00a0Annual Evercore Healthcare Conference: Miami, Florida Investor meetings: December 4 Contact IR@CarisLS.com\u00a0to schedule meetings. About Caris Life Sciences Caris Life Sciences\u00ae (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced &hellip; Continue reading &quot;Caris Life Sciences to Attend Q4 2025 Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-17T14:50:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Caris Life Sciences to Attend Q4 2025 Investor Conferences\",\"datePublished\":\"2025-11-17T14:50:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/\"},\"wordCount\":281,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/830740\\\/Caris_Life_Sciences_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/\",\"name\":\"Caris Life Sciences to Attend Q4 2025 Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/830740\\\/Caris_Life_Sciences_Logo.jpg\",\"datePublished\":\"2025-11-17T14:50:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/830740\\\/Caris_Life_Sciences_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/830740\\\/Caris_Life_Sciences_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/caris-life-sciences-to-attend-q4-2025-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caris Life Sciences to Attend Q4 2025 Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caris Life Sciences to Attend Q4 2025 Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Caris Life Sciences to Attend Q4 2025 Investor Conferences - Market Newsdesk","og_description":"PR Newswire IRVING, Texas , Nov. 17, 2025 \/PRNewswire\/ &#8212;\u00a0Caris Life Sciences\u00ae\u00a0(NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today\u00a0announced that the company will attend the following investor conferences: Wolfe Research&#8217;s 7th Annual Healthcare Conference: New York City, New York Investor meetings: November 18 Citi&#8217;s 2025 Global Healthcare Conference: Miami, Florida Investor meetings: December 3 8th\u00a0Annual Evercore Healthcare Conference: Miami, Florida Investor meetings: December 4 Contact IR@CarisLS.com\u00a0to schedule meetings. About Caris Life Sciences Caris Life Sciences\u00ae (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced &hellip; Continue reading \"Caris Life Sciences to Attend Q4 2025 Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-17T14:50:17+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Caris Life Sciences to Attend Q4 2025 Investor Conferences","datePublished":"2025-11-17T14:50:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/"},"wordCount":281,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/","name":"Caris Life Sciences to Attend Q4 2025 Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.jpg","datePublished":"2025-11-17T14:50:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/830740\/Caris_Life_Sciences_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/caris-life-sciences-to-attend-q4-2025-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Caris Life Sciences to Attend Q4 2025 Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/910765","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=910765"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/910765\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=910765"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=910765"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=910765"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}